SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-016306
Filing Date
2023-05-01
Accepted
2023-05-01 16:51:22
Documents
19

Document Format Files

Seq Description Document Type Size
1 DEF 14A eldn-20230501.htm   iXBRL DEF 14A 1512514
2 GRAPHIC img116179745_0.jpg GRAPHIC 191772
3 GRAPHIC img116179745_1.jpg GRAPHIC 188109
4 GRAPHIC img116179745_2.jpg GRAPHIC 200390
5 GRAPHIC img116179745_3.jpg GRAPHIC 1466701
6 GRAPHIC img116179745_4.jpg GRAPHIC 260801
  Complete submission text file 0000950170-23-016306.txt   8244620

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eldn-20230501.xsd EX-101.SCH 4327
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eldn-20230501_lab.xml EX-101.LAB 9119
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eldn-20230501_pre.xml EX-101.PRE 5570
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eldn-20230501_def.xml EX-101.DEF 4087
13 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20230501_htm.xml XML 364160
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36620 | Film No.: 23874603
SIC: 2834 Pharmaceutical Preparations